TrialA Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma
Trial details
- Registry ID
- NCT05042609
- Phase
- Phase 3
TARX
Tarsier Pharma
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
1Trials in this database
1Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic GlaucomaNCT05042609 | Tarsier Pharma | Phase 3 | Completed | 2023-06-29Actual |
Latest recorded trial changes
A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma
NCT05042609 · Tarsier Pharma
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before
Measure: Anterior Chamber Cell (ACC) Grade on Day 28
+ After
Measure: Anterior Chamber Cell (ACC) Grade = 0 on Day 28 Measure: Anterior Chamber Cell (ACC) Grade = 0 or 1 on Day 28